Supervision on the new crown industry chain
In order to open the way, Guangdong also highlights the investigation and linkage< span>. Development of four major areas: drug development and production, drug business and use, medical devices, and cosmetics< span>All fields and all chainsInvestigation of potential risks, sorting out 16 key risk screening items and refining them into 119 risk points. Among them, pharmaceutical development and production66, pharmaceutical distribution< span>21, Medical Devices22, Cosmetics 10 items, establish a risk inspection list, carry out inspections one by one, and implement sales management.
●In the first quarter, inspectionpharmaceutical development and production units< span>109 times, 46 companies were warned, 45 companies were ordered to rectify, and 3 companies were interviewed.
●InspectionPharmaceutical operating units5134 Second, 406 companies were rectified within a time limit, 4 clues were handed over to the public security organs, and 1 company was ordered to stop operating.
●InspectionMedical Device Manufacturing Business Units11163 373 cases were ordered to be corrected, 303 cases of rectification were completed, 18 cases were interviewed, 75 hidden dangers were investigated, and 61 cases were disposed of.
●In the cosmetic field, cancel the registration of products 672, and 150 problem products were found.
During the current epidemic, Guangdong particularly attaches great importance to the supervision of drug safety and quality in the new crown industry chain . It has conducted special inspections on the new crown inactivated vaccine of Shenzhen Kangtai Biological Products Co., Ltd. 4 times, and urged the company to complete 4 risk sales. Focus on new coronavirus detection reagents, online sales of medical devices, etc.Nine categories of products, five categories of enterprises and platforms, and deploy and carry out rectification in stages Work, carry out special inspections on epidemic prevention and control of denture medical device manufacturers, actively promote the work of antigen detection reagents to ensure safety and promote production, and Ensure the market supply of new crown antigen detection reagents across the country< /span>.
Source: Guangdong Provincial Drug Administration
Edit : Xu Manjia, Yang Liying
First trial: Liang Lijun
Second trial: Li Tingting
Final trial :Cheng Chaohui
01
Vote | The youth in the history of the Centennial League said, which one do you pick the most?
02
Guangdong Provincial Food and Drug Administration’s “triple” innovative service has achieved remarkable results and continued to help the high-quality development of the province’s biopharmaceutical industry
03
Guangdong Provincial Drug Administration Party Secretary and Bureau Changjiang Xiaodong talked about comprehensively strengthening drug regulatory capacity building
04
Guangdong quickly launched the “Sharp Sword”” Three special strike operations of Yunjian and Bright Sword
[Source: Guangdong Drug Administration]
Disclaimer: This article is reproduced for the purpose of conveying more information. If the source is incorrectly marked or infringes your legal rights, please contact the author with the ownership certificate, we will correct or delete it in time, thank you. Email address: [email protected]